Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Comparison of a Single Endpoint to Determine Optimal Initial Warfarin Dosing (5 mg versus 10 mg) for Venous Thromboembolism,

Comparison of a Single Endpoint to Determine Optimal Initial Warfarin Dosing (5 mg versus 10 mg) for Venous Thromboembolism,. in press scheduled for publication in the American J of Cardiology. 2006.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.